0000917520-24-000023.txt : 20240308
0000917520-24-000023.hdr.sgml : 20240308
20240308162226
ACCESSION NUMBER: 0000917520-24-000023
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240306
FILED AS OF DATE: 20240308
DATE AS OF CHANGE: 20240308
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DAVIS ROBERT T. JR.
CENTRAL INDEX KEY: 0001563606
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26224
FILM NUMBER: 24734694
MAIL ADDRESS:
STREET 1: INTEGRA LIFESCIENCES CORPORATION
STREET 2: 311 ENTERPRISE DRIVE
CITY: PLAINSBORO
STATE: NJ
ZIP: 08536
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTEGRA LIFESCIENCES HOLDINGS CORP
CENTRAL INDEX KEY: 0000917520
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 510317849
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1100 CAMPUS ROAD
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 6092750500
MAIL ADDRESS:
STREET 1: 1100 CAMPUS ROAD
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: INTEGRA LIFESCIENCES CORP
DATE OF NAME CHANGE: 19950614
4
1
wk-form4_1709932936.xml
FORM 4
X0508
4
2024-03-06
0
0000917520
INTEGRA LIFESCIENCES HOLDINGS CORP
IART
0001563606
DAVIS ROBERT T. JR.
1100 CAMPUS ROAD
PRINCETON
NJ
08540
0
1
0
0
EVP & President, TT
0
Common Stock
2024-03-06
4
M
0
8736
32.585
A
58241
D
Common Stock
2024-03-06
4
S
0
8348
36.5946
D
49893
D
Non-Qualified Stock Option (right to buy)
32.585
2024-03-06
4
M
0
8736
0
D
2024-03-14
Common Stock
8736
0
D
Represents shares sold in connection with a broker-assisted "sell to cover" cashless exercise transaction to cover the exercise price and withholding taxes upon the exercise of stock options scheduled to expire.
The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $36.57 to $36.65 The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
25% of the stock options vested on the first, second, third and fourth anniversary of the original grant date of March 14, 2016.
/s/ Eric Schwartz; Attorney-in-Fact
2024-03-08